Modified constraint induced movement therapy in children with obstetric brachial plexus palsy: a systematic review.

Obstetric brachial plexus palsy is a condition where a baby's arm is left weak or paralysed after a nerve injury during birth, and some children never fully regain arm function. One rehabilitation approach borrowed from adult and paediatric neurological therapy is modified constraint-induced movement therapy, which restrains the stronger arm to encourage use of the affected one. This review pulled together everything available on that approach specifically for obstetric brachial plexus palsy and found just four studies: a case report, a case series combining the therapy with botulinum toxin injections, a cohort study comparing it to children with cerebral palsy, and one randomised trial comparing it to conventional therapy.

The one point of agreement across these studies was that programmes should run for at least two weeks. Beyond that, the approaches varied so much that no consistent protocol could be identified, and the small number and mixed designs of the studies mean the overall evidence remains limited.

If you're a parent of a child with a birth-related arm nerve injury, you may have come across a therapy called modified constraint-induced movement therapy, which involves restricting the stronger arm so the weaker one is used more often. This review looked at all the research done on this therapy for this specific condition and found only four studies, including a single case report, a small case series, a cohort comparison, and one randomised trial comparing it with usual therapy. The studies agreed that programmes lasted at least two weeks, but they used different methods, which makes it hard to say how well the therapy works or what the ideal approach looks like.

Because there's so little research, and what exists is quite varied, no firm conclusions can be drawn yet about its benefits for children with this condition. Larger, more consistent studies are still needed before clearer guidance can emerge.

This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.

For clinicians weighing whether modified constraint-induced movement therapy (mCIMT) has a role in managing obstetric brachial plexus palsy, this systematic review clarifies just how thin the evidence base currently is. Only four studies met inclusion criteria: one case report, one case series combining mCIMT with botulinum toxin injections in two children, one cohort study comparing 19 children with obstetric brachial plexus palsy to 18 with unilateral cerebral palsy, and one single-blind randomised controlled trial comparing mCIMT with conventional therapy in 39 children.

This mix of study designs, most non-randomised or very small, limits the strength of any conclusions that can be drawn. The review identifies a consistent minimum programme duration of two weeks across studies, but beyond that there is no agreement on intensity, dosage, or specific protocol elements, reflecting substantial heterogeneity. This informs clinical reasoning by highlighting that mCIMT protocols in this population are not standardised, so applying findings from one study to a different clinical context carries uncertainty.

The review does not establish that mCIMT is effective for obstetric brachial plexus palsy overall, nor does it clarify which protocol features matter most; it instead maps out the sparse and inconsistent evidence that currently exists, pointing to a clear gap for larger, more methodologically rigorous studies.